Ciprofloxacin Hydrochloride

盐酸环丙沙星

Report date: 2026/05/09 20:00:18
NMEQIDP

Base Information

Drug NameCiprofloxacin Hydrochloride
Drug Alias NameCyprofloksacyny chlorowodorek环丙沙星盐酸盐Ciprofloxacini hydrochloridumSiprofloksasiinihydrokloridiCiprofloxacin-hydrochlorid +[38] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionBacterial DNA gyrase inhibitorsDNA topoisomerase inhibitors
TargetsBacterial DNA gyraseDNA topoisomerase
Therapy Area/IndicationsAcute BronchitisLower Respiratory Tract InfectionsPerianal abscess +[44] 
Global Approved IndicationsAcute BronchitisLower Respiratory Tract InfectionsPerianal abscess +[38] 
Approved Indications in ChinaInfections
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesFinland +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesGrifols SaSandozLaboratorios Salvat Sa +[7] 
Inactive CompaniesTampere University Of TechnologyLawson Health Research Institute
Active IndicationsAcute BronchitisLower Respiratory Tract InfectionsPerianal abscess +[42] 
Inactive IndicationsAnkle FracturesUrolithiasis

Other Information

ATC CodeJ01MAS01AE
Related LinksWikipediaDrugBankKEGG